Could a gene regulatory network in gut microbes have evolved its elaborate and tightly regulated molecular machinery only to pump out antibiotics indiscriminately? Researchers show this is an ...

A virulent strain of antibiotic-resistant ‘superbug’ bacteria that causes severe disease has been found circulating in a Malaysian hospital, a new study by academics has revealed. The threat ...

Steven Nickolas is a writer and has 10+ years of experience working as a consultant to retail and institutional investors. Andy Smith is a Certified Financial Planner (CFP®), licensed realtor and ...

He says that to find new drugs to combat growing antimicrobial resistance, scientists must “look to more unusual or overlooked sources of antibiotics.” So the team grew the bacteria found in ...

Lariocidin hits drug-resistant bacteria where others fail — by hijacking the ribosome at a new site, bypassing defences, and opening the door to a new generation of antibiotics. Lariocidin ...

The first stage involves prosthesis removal, radical debridement, and placement of an antibiotic-loaded cement spacer combined with systemic antibiotic therapy. Prosthesis reimplantation is performed ...

The antibiotic, branded as Blujepa, is approved for women aged 12 years and older to treat uncomplicated UTIs, which are bacterial infections affecting the lower urinary tract in otherwise healthy ...

Researchers have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including those resistant to existing drugs. The new molecule — isolated from ...

The last time a new class of antibiotics reached the market was nearly three decades ago—but that could soon change, thanks to a discovery by researchers at McMaster University. The discovery of ...

Researchers have discovered a new antibiotic molecule that targets a broad range of disease-causing bacteria — even strains resistant to commercial drugs — and is not toxic to human cells 1.

It is the first in a new class of oral antibiotics approved for this condition in nearly 30 years. UTIs are common bladder infections that typically affect women without underlying health issues.

The last time a new class of antibiotics reached the market was nearly three decades ago - but that could soon change, thanks to a discovery by researchers at McMaster University. A team led by ...